Study aim: The effect of almond porridge, grape juice and chickpea juice on weakness and duration of hospitalization and clinical symptoms due to covid 19 Design: This is a single-center double-blind, placebo-controlled randomized trial with 160 (80 in each group) participants. Settings and conduct: patients with Covid-19 that are hospitalized at AJA hospital will be randomized into treatment and placebo groups and will be assessed at baseline and 3-months and 6-months visits. The primary investigator of the study, who will not be involved in diagnosis and follow-up, will carry out the randomization and allocation using permuted block randomization with blocks of size 4. Treatment allocations will be concealed using opaque envelopes. Participants/Inclusion and exclusion criteria: Inclusion criteria: 1) age between 18 and 65 years 2) Positive PCR test and lung involvement on CXR and positive clinical signs 3) Candidate for inpatient treatment Exclusion criteria: 1) Respiratory distress 2) Hospitalization in the intensive care unit or tracheal intubation Intervention groups: Both study and control groups will receive the same food and covid-19 treatments (standard hospital regimen). During the hospital stay, in addition to the standard hospital regimen, we give the patient a mixture of almond porridge and grape juice between meals at 10 o'clock during the hospital stay. We also give chickpea juice to the patient in the 4 o'clock snack. Main outcome variables: Hospital stay The Fatigue Assessment Scale (FAS) for the assessment of fatigue severity SF-36 questionnaire for the assessment of the quality of life